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We have purified in SDS X.laevis thesaurin a (Mr 50000) which is part of the 42 S storage particles. Its 
N-terminal amino acid is blocked and several peptides obtained by V8 protease treatment were purified 
and sequenced. As expected from one of the functional roles of the 42 S particles (tRNA binding, protection 
against deacylation and exchange with the ribosome), the amino acid sequence of thesaurin a was found 
to be closely related to that of the elongation factor EF-b. We suggest hat all three proteins involved in 
5 S RNA and tRNA storage in previtellogenic oocytes, TFIIIA, thesaurin a and thesaurin b, have a dual 
function: storage and a role in transcription or in protein synthesis. 
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1. INTRODUCTION 
In previtellogenic oocytes of Xenopus laevis 
large amounts of 5 S RNA and tRNA are stored in 
nucleoprotein particles [ 1,2], the thesaurisomes 
[3]. The larger of these particles sediments at 42 S 
and contains, in addition to tRNA and 5 S RNA 
[1,2], two proteins with apparent A4, values of 
50000 (thesaurin a) and 40000 (thesaurin b) [4,5]. 
Thesaurin a is the most abundant protein in the 
cytoplasm of previtellogenic oocytes, amounting 
to about 7% of the protein content of these cells 
[4]. Thesaurin a binds tRNA and thesaurin b binds 
5 S RNA [4,5]. The 42 S particles are directly in- 
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volved in protein synthesis [6,7]. Not only do the 
particles exchange tRNA with the ribosomes [6,7] 
but they also sustain a low-rate polymerization of 
amino acids [S], which may be the consequence of 
the storage conditions provided to aminoacyl 
tRNA in the particles [8]. These conditions are 
such that aminoacyl tRNA cannot be discharged in 
the particles [9]. This suggests that some kind of 
relationship might exist between thesaurin a and 
EF-la [6,7], which exclusively binds aminoacyl 
tRNA [lo] and protects it against deacylation [lo]. 
Thesaurin a shares immunological cross-reactivity 
with Artemia salina EF-lcu [7]. In this paper we 
report that the amino acid sequence of X. laevis 
thesaurin a is homologous to that of EF-lcu from 
A. salina [ 111, Homo sapiens [ 121 and X. laevis 
(Krieg, P. and Melton, D., unpublished). 
2. EXPERIMENTAL 
The 42 S particles present in previtellogenic 
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oocytes of X. laevis were purified by centrifuga- 
tion into a linear sucrose gradient (15-30%) w/v, 
14 ml, containing 50 mM Tris-HCl, pH 7.6, 
25 mM KCl, 5 mM MgC12, 0.1 mM DTT) at 
280000 x g for 4 h in Beckman SW 41 Ti rotor. 
The particle-containing fractions were treated with 
0.1 vol. of 500 mM Tris-HCI, pH 6.8, 10 mM 
EDTA, 20% (w/v) SDS, 10% (v/v) 2-mercapto- 
ethanol, and heated for 70 s at 100°C. After a low- 
speed centrifugation the samples (2 ml, containing 
about 25 Fg of protein) were injected on a 
preparative TSK 3000 SWG column (600 X 
21.5 mm). This column is designed for gel filtra- 
tion of large samples by high-performance liquid 
chromatography (HPLC). Elution was carried out 
at a flow rate of 4 ml/min with 30 mM Hepes, 
10 mM imidazole, pH 7, 200 mM sodium acetate, 
0.1 mM DTT, 0.1% (w/v) SDS (room tem- 
perature) . 
Thesaurin a purified by HPLC was concentrated 
lo-fold in Centricon 10 and digested by 
staphylococcal V8 protease [13] (Miles) for 1 h at 
37°C at a thesaurin a/V8 ratio of 3.4/l (w/w). 
1 vol. thesaurin a in HPLC buffer was added to 
1 vol. of 125 mM Tris-HCl, pH 6.8, 1 mM EDTA, 
0.1% SDS (w/v), heated for 70 s at 100°C before 
addition of 2 vol. V8 protease in the same buffer, 
but containing 10% (v/v) glycerol. Proteolysis was 
stopped [13] and the samples were loaded on a 
10.4% polyacrylamide gel 1141. Slices of 
Coomassie blue stained gels containing a single V8 
protease-derived peptide were rinsed (3 x 1 h) in 
bidistilled water, electroeluted (Biotrap) in 50 mM 
Tris-HCl, 340 mM glycine, pH 8.8, 2 mM EDTA, 
0.1 mM DTT, 0.1% (w/v) SDS for 4 h at 70 mA 
and 180 V. The electroeluted peptides were exten- 
sively dialyzed (15 h and 2 x 2 h) in a Spectrapor 
2000 dialysis bag against 1 1 of 10 mM (NH&C03, 
0.01% (w/v) SDS, in order to reduce the salt and 
SDS concentrations, and concentrated lo-fold in a 
Centricon 10 before sequencing. 
The peptides were sequenced using an Applied 
Biosystems 470-A gas-phase sequenator with on- 
line PTH analysis. 
3. RESULTS AND DISCUSSION 
The first step in the purification of thesaurin a 
from X. laevis immature ovaries is a sucrose densi- 
ty centrifugation [3,4], which separates the 
ribosomes (80 S) from the two thesaurisomes: the 
42 S particles, described in the introduction, and 
the 7 S particles, made up of TFIIIA and 5 S RNA 
[ 15-171. The fractions containing the 42 S par- 
ticles were pooled, dissociated with SDS and 
2-mercaptoethanol and loaded on an HPLC gel 
filtration preparative column (fig. 1A). SDS was 
found to be necessary to maintain thesaurin a in 
solution after removal of the RNA. Three peaks 
were recovered between the V,,, containing high- 
molecular-mass aggregates and some mRNA, and 
the I’t peak (2-mercaptoethanol). Gel elec- 
trophoresis of the eluted fractions (fig.lB) shows 
that the first peak contains thesaurin a and 
thesaurin b and that the former protein is pure in 
some fractions in the leading edge of the peak 
(fig.lB). The second and third peaks contain 5 S 
RNA and tRNA, respectively. 
Since the N-terminal amino acid of thesaurin a 
is blocked, this protein cannot be sequenced irect- 
ly. Therefore, we have prepared and purified 
several peptides, using staphylococcal V8 protease 
which is active in the presence of SDS (fig.2). The 
peptides were separated by SDS-PAGE and 
recovered by electroelution with the precautions 
described by Hunkapiller et al. [141 to avoid N- 
terminal blocking. The partial sequence of the pep- 
tides a3, a.+, as, a7 and as is given in fig.3 together 
with the corresponding sequences of A. salina [ 1 l] 
and human [12] EF-la. There is a strong conserva- 
tion of the primary structure in the sequenced 
regions: nearly 70% of the amino acids are iden- 
tical in X. iaevis thesaurin a and human or A. 
salina EF-lcr. Furthermore, most of the dif- 
ferences occur in regions where human and A. 
salina EF-1~ also differ (fig.3). 
The question may be raised whether thesaurin a 
is identical to X. laevis EF-la. The sequence of the 
X. faevis EF-la (Krieg, P. and Melton, D., un- 
published) demonstrates that the two proteins are 
different: they differ in all the positions for which 
a difference is noted between X. laevis thesaurin a 
and H. sapiens EF-la (see fig.3). An additional 
difference is residue 271 which is isoleucine in X. 
faevis EF-la. Other lines of evidences also lead to 
the conclusion that X. laevis thesaurin a is not 
identical to X. laevis EF-lcu. Purified thesaurin a is 
highly insoluble in the absence of SDS or urea, 
whereas EF-la is soluble 1181. X. Iaevis EF-lcz 
sediments as a 5-7 S particle in the sucrose density 
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Fig.%. Purification of peptides from thesaurin a. HPLC- 
derived thesaurin a (lane 7) was digested by 
staphylococcal V8 protease (lane 1). Five peptides were 
purified: a3 (lane 2), a5 (lane 3), a4 (lane 4), a7 (lane 5) 
and as (lane 6). Lane 8 contains a non-purified 42 S 
particle sample. 
Fig. 1. (A) Separation of the 42 S particle components by 
HPLC gel filtration chromatography. Volume of the 
fracations: 1.3 ml. (B) SDS-PAGE (10.4%) analysis of 
the HPLC fractions showing purification of thesaurin a, 
5 S RNA and tRNA. Lanes: 1, 42 S particles before 
chromatography; 2-6, tubes 15-19 of A; 7, pool of the 
5 S RNA-containing fractions; 8, pool of the tRNA- 
containing fractions; l-6, Coomassie blue staining; 7 
and 8, silver staining. 
gradient [7], whereas thesaurin a is exclusively 
associated with the 42 S particles. Finally, EF-ICZ 
has a slightly higher apparent molecular mass than 
EF-lcu on SDS-PAGE [7]. 
Homology between human, A. sulina EF-la and 
the corresponding elongation factor of bacterial 
and organellar origin (EF-Tu) has been 
demonstrated [l 1,121. Since the structure of tRNA 
is highly conserved in evolution, it is not surprising 
that the sequences of the proteins whose main 
function is to bind aminoacyl tRNA are also highly 
conserved. In particular, Lys 272, one of the 
residues involved in tRNA binding, is conserved in 
thesaurin a, in all of the EF-las sequenced so far 
[12] and in EF-Tu [19]. Residues 144-149 which 
are considered part of a guanine nucleotide 
binding site (called region II by Brands et al. [12]) 
are identical in thesaurin a and in EF-la, known as 
a GTP-binding protein. These residues are also 
found in other GTP-binding proteins ‘or in the 
RAS proteins [12]. 
We speculate that thesaurin a is a translation 
factor modified to perform a dual function in 
previtellogenic oocytes: (i) transfer of aminoacyl 
tRNA to the ribosomes during elongation [6,7]; 
and (ii) long-term storage of aminoacyl tRNA 
[3,9]. The latter function is prominent in 
previtellogenic oocytes but much less so in later 
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Fig. 3. Comparison of the partial amino acid sequences of X. luevis thesaurin a, A. sulina [ 1 l] and H. sapiens [ 121 EF- la. 
Amino acid residues are shown by single letter symbols. Letter X indicates an unknown residue. Homologous sequence 
regions are boxed. Five V8 protease-derived peptides of thesaurin a were sequenced. Asterisks indicate the start of a 
guanine nucleotide binding site [12]. The plus sign (residue 272) indicates a conserved amino acid residue involved in 
tRNA binding [ 12,191. Lysine 3 17 is modified as trimethyllysine in A. safina EF-lcu [ 1 l] but not in X, faevis thesaurin 
a. Peptides a7 and as overlap partially: the first amino acid residue of peptide as corresponds to the twelfth residue of 
peptide a7. This is also true of peptides a4 and as: the first amino acid residue of peptide a5 corresponds to the sixth 
residue of peptide a.+. 
oogenesis. Accordingly, thesaurin a disappears in 
vitellogenic oocytes [3] whereas EF-lcu progressive- 
ly accumulates [7]. The abundance of EF-Tu in E. 
coli (5.5% of total proteins) is such that Clark [lo] 
has suggested a storage function for this protein. 
EF-la is certainly less abundant in eukaryotic cells 
[20] than EF-Tu in bacteria, so that a possible 
storage function for EF-lcu in the latest stages of 
oogenesis or in somatic cells would certainly be 
secondary to the elongation factor function. The 
main difference between EF-la and thesaurin a 
would be that thesaurin a, not only binds 
aminoacyl tRNA, but is also able to interact with 
the other components of the 42 S particle, i.e. 
thesaurin b and, directly or indirectly, 5 S RNA. 
The resulting c6mplex is a more efficient storage 
particle than the individual components in terms of 
bound water and hence of occupied space and also 
in terms of stability of the aminoacyl tRNA [9,21]. 
In previtellogenic oocytes, three abundant pro- 
teins are involved in 5 S RNA and tRNA storage, 
TFIIIA, thesaurin a and thesaurin b. It has already 
been shown that TFIIIA has a dual function, i.e. 
storage [15] and transcription of 5 S RNA [16,17]. 
We would not be surprised if thesaurin b, like 
thesaurin a and TFIIIA, also has a dual function 
and is involved not only in storage of RNA but 
also in transcription or protein synthesis. 
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